O Shaughnessy Asset Management LLC Sells 6,650 Shares of Danaher Co. (NYSE:DHR)

O Shaughnessy Asset Management LLC reduced its position in shares of Danaher Co. (NYSE:DHRFree Report) by 11.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 50,530 shares of the conglomerate’s stock after selling 6,650 shares during the period. O Shaughnessy Asset Management LLC’s holdings in Danaher were worth $11,599,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in shares of Danaher by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate’s stock worth $13,715,641,000 after buying an additional 315,912 shares in the last quarter. Norges Bank acquired a new stake in Danaher during the 4th quarter valued at $2,130,740,000. Bank of New York Mellon Corp raised its position in Danaher by 5.4% in the 4th quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock valued at $1,971,609,000 after purchasing an additional 441,012 shares during the last quarter. Fisher Asset Management LLC raised its position in Danaher by 0.6% in the 4th quarter. Fisher Asset Management LLC now owns 4,578,945 shares of the conglomerate’s stock valued at $1,051,097,000 after purchasing an additional 26,305 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Danaher by 3.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,066,755 shares of the conglomerate’s stock worth $933,524,000 after purchasing an additional 135,047 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on DHR. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target for the company in a report on Friday, December 13th. Barclays dropped their target price on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Royal Bank of Canada reissued an “outperform” rating and set a $277.00 price target (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Scotiabank began coverage on shares of Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective for the company. Finally, JPMorgan Chase & Co. decreased their price objective on Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Five investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $278.24.

Check Out Our Latest Research Report on DHR

Insider Buying and Selling at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 11.10% of the company’s stock.

Danaher Trading Down 0.4 %

Shares of NYSE DHR opened at $205.01 on Tuesday. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company’s fifty day moving average is $213.91 and its 200-day moving average is $235.91. The stock has a market cap of $146.52 billion, a price-to-earnings ratio of 38.83, a P/E/G ratio of 2.66 and a beta of 0.82.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business earned $2.09 earnings per share. Equities research analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.62%. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s dividend payout ratio (DPR) is 24.24%.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.